Member Info for mazik

Paul2566 point taken thanks

Instituition buying and holding for a reason, takeover or positive future..35p or 50p this qtr3. Imo

Paul2566, point taken reward against risk is substantial than its competitors race for oral vaccine is on and we are ahead phase 3 trials results we should know by july/August.. whilst Vaxart are at phase 1 and shares have jumped by 50% this week to $9.. apart from covid, we are working on treatment of Epilipsy and dementia, all positive news coming from the management and they are doing it :-) topping up whilst it's cheap.

Takeover prelude of 2nd court hearing...imo positive buying this morning

This has enormous potential with oral vaccine within this qtr3, earlier than Vaxart in US at phase 2..when we complete phase 3 successfully in Israel and Who and Fda'approval sky will be the limit imo...50p plus

Jackdaw patience is needed in my opinion Aussie holders are selling before mxc is delisted in ASX, it's a guess. Your average is better than most of us £20k with 5p average, a sore holder....i am holding for gold where hopefully sky is the limit..gla

Bigbob thanks

Some selling shares worth £20 t0 £50...are these real shareholders? Or Aussie's selling before consolidation or delisted from asx before they join LSE main listing.

Diligent agree with u, by next month 10p plus , surprised it's holding so low..

Jetjock agree this should be rerated after excellent acquisition RNS, 10% sellers will regret but thanks to short termers gives chance to topup...GLA

Smartic-midas double figures hopefully in June, 60p that will see me off , with relief therapeutics market cap over a billion not surprised where we will move to with a lot of news in the pipeline..phase 3 results from Israel and extract and two other products in the pipeline...as Roby says Sky is the limit.

Bladerunner sorry u have a negative assumption and sold 50% of your holding
at a loss...well I am here for profitable ride of a 100% at least, though my average is above 7p reduced to 5p by averaging with 600k shares..too early to call it a day or trade. My target is 20p by end of July and 50p by end of the year...Patience is the key here...

Not surprised two products in phase 2, third in phase 3 and it is poised to supply global phytocannabinoid with growing base and distribution we are moving toward's double figures Imo.

Smartic absolutely....topup opportunity, but feel news will come out sooner than later..imo

Kanobo already market cap over 93 million, in comparison we are already developing and supplying affordable phytocannoboid to patients globally , offering two demanding conditions epilepsy dementia and hopefully covid19 which is on phase 3 trial in Israel. Expect like Roby said Sky is the limit...

Massive potential once Mm stop playing games...imo 310% increase in profits 100m Rmr equivalent to Market cap, all buys, holding for 15p.

Not many have made money with kibo

Agree holding and adding to this growth industry...imo

Curse of the past....imo.

Smartic thanks, same opinion .